key: cord-0780078-grbdzl67
authors: Ong, Sean Wei Xiang; Lee, Pei Hua; Tan, Yian Kim; Ling, Li Min; Ho, Benjamin Choon Heng; Ng, Ching Ging; Wang, Dong Ling; Tan, Boon Huan; Leo, Yee-Sin; Ng, Oon-Tek; Wong, Michelle Su Yen; Marimuthu, Kalisvar
title: Environmental contamination in a coronavirus disease 2019 (COVID-19) intensive care unit—What is the risk?
date: 2020-10-21
journal: Infection control and hospital epidemiology
DOI: 10.1017/ice.2020.1278
sha: fcaa689314446264ffa01e5b8bdc592ab2e28253
doc_id: 780078
cord_uid: grbdzl67

BACKGROUND: The risk of environmental contamination by severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in the intensive care unit (ICU) is unclear. We evaluated the extent of environmental contamination in the ICU and correlated this with patient and disease factors, including the impact of different ventilatory modalities. METHODS: In this observational study, surface environmental samples collected from ICU patient rooms and common areas were tested for SARS-CoV-2 by polymerase chain reaction (PCR). Select samples from the common area were tested by cell culture. Clinical data were collected and correlated to the presence of environmental contamination. Results were compared to historical data from a previous study in general wards. RESULTS: In total, 200 samples from 20 patient rooms and 75 samples from common areas and the staff pantry were tested. The results showed that 14 rooms had at least 1 site contaminated, with an overall contamination rate of 14% (28 of 200 samples). Environmental contamination was not associated with day of illness, ventilatory mode, aerosol-generating procedures, or viral load. The frequency of environmental contamination was lower in the ICU than in general ward rooms. Eight samples from the common area were positive, though all were negative on cell culture. CONCLUSION: Environmental contamination in the ICU was lower than in the general wards. The use of mechanical ventilation or high-flow nasal oxygen was not associated with greater surface contamination, supporting their use and safety from an infection control perspective. Transmission risk via environmental surfaces in the ICUs is likely to be low. Nonetheless, infection control practices should be strictly reinforced, and transmission risk via droplet or airborne spread remains.

(Received 28 August 2020; accepted 9 October 2020)

The coronavirus disease 2019 (COVID- 19) pandemic has spread at an exponential rate since the first recognition of the novel virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and has placed a disproportionate strain on intensive care resources worldwide. 1, 2 Healthcare facilities have been implicated as centers of transmission, in both tertiary-care hospitals and long-term care facilities. [3] [4] [5] [6] [7] However, the frequency of nosocomial transmission in ICUs is less clear, and no large ICU outbreaks have been reported to date. ICUs have been important sites of nosocomial transmission and superspreading events in previous coronavirus outbreaks, in part due to the increased frequency of use of aerosol-generating procedures (AGPs), particularly endotracheal intubation. 8, 9 Other noninvasive oxygenation strategies, such as positive pressure noninvasive ventilation (NIV) or high-flow nasal oxygen (HFNO), have been shown to be beneficial in reducing mortality and progression to intubation in hypoxemic respiratory failure. 10 However, from an infection control perspective, these strategies are AGPs with an increased risk of aerosol transmission and environmental contamination via droplet dispersion. The extent of transmission risk through environmental contamination from these procedures remains unclear, and recommendations from different regulatory authorities have varied in their definition of AGP and their relative risk. 11 Extensive environmental contamination by SARS-CoV-2 in the environments of infected patients has been demonstrated in multiple studies in both healthcare and community settings, [12] [13] [14] [15] [16] [17] [18] [19] [20] but no study has focused specifically on the extent of such contamination in an ICU setting nor correlated patient and disease factors with the extent of environmental contamination, including the impact of ventilation modalities. A study found that environmental contamination decreased sharply after day 7 of illness, 13 which was hypothesized to be related to the similar decrease in viral load from the upper respiratory tract in the same time frame. [21] [22] [23] In this study, we evaluated the extent of environmental contamination by SARS-CoV-2 in an ICU setting and correlated these findings with patient and disease factors to assess the relative safety of different oxygenation methods with regard to environmental contamination. We hypothesized that despite the increased use of noninvasive ventilatory methods, environmental contamination in the ICU would be lower (1) because most COVID-19 patients typically deteriorate in the second week of illness, during which period viral shedding decreases 24, 25 and (2) because closed-loop ventilatory circuits contain and limit the spread of contaminating droplets or aerosols. Additionally, we conducted a literature review to assess the extent and frequency of ICU environmental contamination across different healthcare systems worldwide.

This study was conducted in 2 dedicated COVID-19 ICUs in the National Centre for Infectious Diseases, the largest outbreak center for COVID-19 in Singapore. These ICUs admitted both patients with confirmed COVID-19 requiring intensive care as well as suspected patients with respiratory symptoms undergoing evaluation to rule out COVID-19. Environmental sampling was carried out at 5 separate time points in the rooms of all patients with active COVID-19 infection, defined by a positive SARS-CoV-2 polymerase chain reaction (PCR) test from any respiratory sample. Patients were housed in single airborne infection isolation rooms (AIIRs) with attached anterooms. Patients who had ceased viral shedding (ie, latest respiratory sample was negative for SARS-CoV-2 PCR) were excluded. In total, 10 sites were sampled from each room (Supplementary Fig. 1 online) . In addition, 5 points in the common areas in the ICU were sampled, as well as 5 points in the staff pantry shared between both ICUs ( Supplementary Fig. 2 online) .

Environmental samples were collected by the same study team member throughout all sampling cycles using EnviroMax Plus premoistened macrofoam sterile swabs (Puritan Medical Products, Guilford, ME). The same surface area was swabbed for each sampling site using a standardized technique. This same environmental sampling protocol has been used in other studies at our center and has achieved consistent detection results. 12, 13 All samples were kept at 4°C and were transported to a biosafety level 3 (BSL-3) laboratory for storage and testing within 3 days of sampling.

Clinical data including day of illness, type of oxygenation or ventilatory support, use of AGPs (intubation, extubation, open suctioning, nebulization, or bronchoscopy), and clinical cycle threshold (Ct) value (if available) were collected from the electronic medical record using a standardized case report form. No patient identifiers were recorded, and data were stored on a secured server. Informed consent was waived as clinical data were collected as part of an outbreak investigation under the Infectious Diseases Act, authorized by the Ministry of Health, Singapore.

Routine twice-daily environmental cleaning in the ICU rooms was performed by housekeeping staff, using 5,000 parts per million (ppm) sodium dichloroisocyanurate (NaDCC) for environmental surfaces and 1,000 ppm NaDCC for the floor. Cleaning of common areas was also performed twice daily with 1,000 ppm NaDCC for the floor and high-touch surfaces. All environmental sampling was conducted in the morning before the scheduled environmental cleaning (ie, the last cleaning time was the afternoon prior to environmental sampling).

Sample RNA extraction was performed using the QIAamp viral RNA mini kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. Real-time PCR assays targeting the envelope (E) gene 26 and orf1ab assay adapted from Drosten et al 27 were used for the detection of SARS-CoV-2 RNA. For the E gene assay, a 20 μL reaction mix was prepared with 12.5 μL of SuperScript III Platinum One-Step qRT-PCR Kit (Thermofisher Scientific, Waltham, MA) buffer, 0.75 mM Mg 2 SO 4 , 5 μL of RNA, 400 nM each of the forward primer (E_Sarbeco_F1-ACAGGTACGTTAATAGTTAATAGCG T) and reverse primer (E_Sarbeco_R2-ATATTGCAGCAGTA CGCACACA) with 200 nM of probe (E_Sarbeco_P1-(FAM) ACACTAGCCATCCTTACTGCGCTTCG (BHQ1)). Thermal cycling conditions included reverse transcription at 55°C for 10 minutes, an initial denaturation at 95°C for 5 minutes, followed by 45 cycles of 95°C for 15 seconds, 58°C for 1 minute. For the orf1ab assay, a 20 μL reaction mix was prepared with 12.5 μL SuperScript III Platinum One-Step qRT-PCR Kit buffer, 0.5 mM Mg 2 SO 4 , 5 μL RNA, 800 nM each of the forward primer (Wu-BNI-F-CTAACATGTTTATCACCCGCG) and reverse primer (Wu-BNI-R-CTCTAGTAGCATGACACCCCTC) with 400 nM of probe (WU-BNI-P-(FAM) TAAGACATGTACGTGCATGGATTGGCT T (BHQ1)). Thermal cycling conditions included reverse transcription at 55°C for 10 minutes, an initial denaturation was conducted at 95°C for 5 minutes, followed by 45 cycles of 95°C for 15 seconds and 60°C for 1 minute. All samples were run in duplicate and with both assays with positive and negative controls with each sample run. Positive detection was recorded as long as amplification was observed in at least 1 assay.

Positive swabs by PCR from the common area and staff pantry were further evaluated for virus viability via cell culture. Monolayers of Vero C1008 cells (ATCC-1586) in T25 flasks were inoculated with 1 mL inoculum (500 μL of the swab sample and 500 μL of Eagle's MEM) and cultured at 37°C, 5% CO 2 with blind passage every 7 days. Also, 140 μL cell culture was used for RNA extraction and real-time PCR twice per week to monitor changes in target SARS-CoV-2 genes as an indication of successful viral replication. In the absence of cytopathic effects and real-time PCR indication of viral replication, blind passages continued for a total of 4 passages before any sample was determined to be negative of viable SARS-CoV-2 virus particles.

Extent of ICU contamination was compared with previously published historical data from 30 rooms (27 general ward and 3 ICU) from our center. 13 Categorical variables were compared using the Fisher exact test, and continuous variables were compared using the Mann-Whitney U test. Binary logistic regression analysis was used to determine odds ratios (ORs) and 95% confidence intervals (CIs) for variables associated with presence of environmental contamination. P < .05 was considered significant, and all tests were 2-tailed. Analyses were performed using Stata version 13 software (StataCorp, College Station, TX).

Other studies evaluating environmental contamination of hospital environments by SARS-CoV-2 were analyzed and compared in relation to our study results. We searched PubMed for manuscripts in English published before July 19, 2020, using varying combinations of the search terms "environmental," "contamination," "SARS-CoV-2," "COVID-19," and "hospital." All manuscripts that reported results of environmental sampling in hospital environments were included and results were extracted and compared.

In total, 200 samples from 20 patient rooms were collected across 5 sampling time points; 60 samples from the ICU common areas were collected across 3 sampling time points; and 15 samples from the staff pantry were collected across 3 sampling time points. Of the 20 patients whose rooms were sampled, the median age was 51. Moreover, 7 patients (35%) were intubated and mechanically ventilated, 9 (45%) were receiving HFNO, and 4 (20%) did not receive any supplementary oxygen or ventilatory support. These last 4 patients were in the ICU for closer monitoring for other nonrespiratory complications (eg, myocardial infarction or arrhythmias requiring cardiac monitoring). Also, 3 patients (15%) had AGPs performed within the 24 hours prior to sampling.

Overall, 14 rooms had at least 1 site that was contaminated (median number of sites, 2; IQR, 1-2; range 1-5) ( Table 1 ). The most frequently contaminated sites were the bed rail and floor (30%), followed by the air outlet vent (25%) and infusion pumps (20%) (Fig. 1) . Presence of environmental contamination was not significantly associated with age, sex, day of illness, ventilatory mode, AGP, or clinical Ct value (Table 2) . Contamination was identified in rooms with patients on mechanical ventilation, HFNO, as well as those not requiring any ventilatory support. Viral cell culture was not attempted on patient room samples due to resource limitations.

Results from this study were compared to historical data from 27 general ward rooms and an additional 3 ICU rooms to assess the differences in environmental contamination between both settings. Both studies were conducted done at the same center and by the same study team; thus, the environmental sampling protocol and hospital environmental decontamination protocols were unchanged. Comparing all ICU rooms with all general ward rooms, although the proportion of rooms with any environmental contamination were similar, there appeared to be less contamination in the ICU, with a lower number of sites and percentages of sites contaminated (Table 3 ). However, due to possible confounding factors, tests were not performed to determine the statistical significance of this difference.

Of the 60 samples collected from the ICU ward common areas, 6 (10%) were positive for SARS-CoV-2: 5 samples from the floor and 1 sample from a desktop computer outside the patient room (Table 4 ). Of the 15 samples collected from the staff pantry, 2 (13.3%) were positive: 1 sample from the floor and 1 sample from a refrigerator door handle (Table 4 ). All samples were negative on viral cell culture.

In total, 22 studies were identified that conducted environmental sampling of SARS-CoV-2. However, 2 studies were excluded because they were conducted outside of acute healthcare settings, 1 in a hotel quarantine facility and 1 in a community long-term care facility. 18, 28 Of the 20 remaining studies, 9 did not conduct any sampling in the ICU (Table 5) . No study specifically focused on environmental contamination in the ICU, and the number of ICU samples ranged from 24 to 218 (median, 35; with 2 studies not stating the precise number of ICU samples). Percentage contamination of all environmental samples from ICU patient rooms ranged from 0 to 44%. Only 2 studies performed viral cultures, and these results were negative for all samples. Because sampling protocol, patient profile, and environmental set-ups differed greatly between studies, further statistical analyses were not performed to assess statistical differences between studies.

In this study, we report the presence and extent of environmental contamination by SARS-CoV-2 in a dedicated COVID-19 ICU. The overall contamination rate was low, and there was no difference in environmental contamination between those on mechanical ventilation or HFNO compared to those on room air. We also found limited contamination of the ICU common areas outside patient rooms.

Compared to other environmental sampling studies (Table 4 ), the degree of environmental contamination in the ICU was lower in our cohort, with 14% of patient room samples testing positive compared to a median of 29% (range, 0-44%) in the other 6 studies from which data were available. However, variation in sampling technique, patient profile, environmental ventilation settings, cleaning methods, and study design limits direct comparisons with other studies. Compared to an earlier study at our center that utilized the same standardized sampling protocol, 13 the extent of environmental contamination in the ICU was lower than in the general wards (with overall 26.5% of collected samples testing positive).

The lower extent of environmental contamination seen in the ICUs could be due to several reasons. First, viral shedding has been reported to peak in the first week of illness and to decrease thereafter, 21, 22 which coincides with the time in which most patients develop respiratory complications necessitating ICU admission. 24, 25 The median day of illness (day 14) during sampling in our cohort is consistent with this. Second, patients in the ICU are confined to their bed and unable to walk around the room, thus reducing the chance of direct or indirect droplet spread. The patient with the greatest contamination in our study (50% of surfaces contaminated) was not requiring ventilatory support and was ambulant. Third, closed ventilatory circuits in mechanically ventilated patients likely limit the extent of aerosol or droplet dispersion from respiratory secretions. Su et al 29 : : : X : : : : : : : : : : : : : : : : : : : : : : : : Increased surface contamination was not associated with mechanical ventilation or HFNO, which suggests that such ventilatory modalities do not enhance SARS-CoV-2 viral dispersion. 30 Although we did not directly measure aerosol or droplet generation, surface contamination may be used as a surrogate in assessing the extent of such generation because aerosols and droplets are deposited on environmental surfaces via gravity. In vitro studies using manikins and smoke dispersion have found that HFNO did not increase dispersion distance compared to simple oxygen or Venturi masks. 31,32 HFNO was also not associated with increased environmental contamination for bacterial pneumonia in a randomized-controlled trial comparing its use with conventional oxygen masks. 33 Our results add to the data supporting the use of HFNO in hypoxemic respiratory failure in COVID-19 from an infection control perspective.

We did not find AGPs to be associated with increased environmental contamination, though only 3 patients underwent AGPs in the 24-hour window prior to sampling, and this small sample size limits conclusive interpretation. AGPs should still be considered high-risk procedures in terms of infection transmission. Novel engineering solutions, such as protective aerosol barriers or hoods, have been proposed to limit the aerosol and droplet dispersal associated with AGPs. 34, 35 However, there has been concern regarding breach of PPE and delayed intubation times associated with some of these contraptions, and their routine use cannot be recommended until more data emerge. 36 The contamination of surfaces in the common area and staff lounge, while unexpected, is likely to be of low impact in terms of infection transmission risk. The Ct values were high and close to the limit of detection, meaning that the amounts of nucleic acid detected were minute. A lower Ct value has been shown to correlate with successful isolation in viral culture, 21,37 with a cutoff of 24 in a study in which clinical samples were assessed. 37 Zhou et al 38 have also demonstrated in in vitro studies that inoculated environmental samples with a Ct value >30 would not be positive on culture. Consistent with this, we were unable to isolate virus from these specimens. Similar to our findings, contamination of common areas, including water dispenser buttons and desktop computers, was also reported by Wu et al. 14 Small amounts of nucleic acid could have been deposited on surfaces outside patient rooms through cross contamination after contact with the floor, shoes, or other fomites exiting patient rooms. Although the risk of infection from contact with such contaminated surfaces is infinitesimally small, attention should nonetheless be given to rigorous infection control precautions, decontamination protocols, and strict hand hygiene.

This study has several limitations. First, we could not perform viral culture on all samples that tested positive by PCR due to resource limitations, and we tested only a subset of positive samples from the common area and staff pantry, as we considered the downstream implications on infection control policy to be greater if this contamination was viable virus. PCR positivity alone for the samples taken from the patient rooms does not equate to infective virus, and the PCR assays may have detected nonviable viral nucleic acid. However, because we compared environmental contamination across various patient groups, RNA contamination may act as an acceptable outcome measure. Second, the sample size was small with only 20 patient rooms sampled; thus, this study may have been underpowered to detect smaller differences with regard to patient or disease factors affecting the degree of environmental contamination. Third, there were no patients receiving NIV; hence, we could not assess the potential impact of NIV.

In conclusion, environmental contamination was seen in the ICU, both in patient rooms and common areas. Contamination did not differ depending on the mode of ventilatory support, supporting the safe use of HFNO from an infection control perspective. The frequency and extent of contamination in the ICU was lower compared to general ward settings. Although the infectious risk of horizontal transmission from contaminated surfaces is low, attention should be given to the maintenance of strict hygiene, decontamination, and infection control precautions.

Hospital preparedness for COVID-19: a practical guide from a critical care perspective

Estimated demand for US hospital inpatient and intensive care unit beds for patients with COVID-19 based on comparisons with Wuhan and Guangzhou, China

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility

Clinical and transmission characteristics of COVID-19-a retrospective study of 25 cases from a single thoracic surgery department

Nosocomial outbreak of COVID-19 pneumonia in Wuhan, China

First reported nosocomial outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric dialysis unit

Aerosol-generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review

Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto

Association of noninvasive oxygenation strategies with all-cause mortality in adults with acute hypoxemic respiratory failure: a systematic review and meta-analysis

Aerosol-generating procedures and infective risk to healthcare workers: SARS-CoV-2-the limits of the evidence

Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient

Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients

Environmental contamination by SARS-CoV-2 in a designated hospital for coronavirus disease 2019

Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards

Environmental contamination of SARS-CoV-2 in healthcare premises

Environmental contamination of SARS-CoV-2 during the COVID-19 outbreak in South Korea

Detection of severe acute respiratory syndrome coronavirus 2 RNA on surfaces in quarantine rooms

Air and environmental sampling for SARS-CoV-2 around hospitalized patients with coronavirus disease 2019 (COVID-19)

Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit

Virological assessment of hospitalized patients with COVID-2019

Detection of SARS-CoV-2 in different types of clinical specimens

Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

Environmental detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from medical equipment in long-term care facilities undergoing COVID-19 outbreaks

Masks and closed-loop ventilators prevent environmental contamination by COVID-19 patients in negative-pressure environments

High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion

Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks

Airflow and droplet spreading around oxygen masks: a simulation model for infection control research

Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial

COVID-19: minimising risk to healthcare workers during aerosol-producing respiratory therapy using an innovative constant flow canopy

Introducing the "Corona Curtain": an innovative technique to prevent airborne COVID-19 exposure during emergent intubations

The aerosol box for intubation in coronavirus disease 2019 patients: an in-situ simulation crossover study

Predicting infectious SARS-CoV-2 from diagnostic samples

Investigating SARS-CoV-2 surface and air contamination in an acute healthcare setting during the peak of the COVID-19 pandemic in London

SARS-CoV-2 environmental contamination associated with persistently infected COVID-19 patients. Influenza Other Respir Viruses

SARS-CoV-2 RNA detection in the air and on surfaces in the COVID-19

Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy

Environmental contamination by SARS-CoV-2 of an imported case during incubation period

Do established infection prevention and control measures prevent spread of SARS-CoV-2 to the hospital environment beyond the patient room?

Environmental surface testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during prolonged isolation of an asymptomatic carrier

Environmental virus surveillance in the isolation ward of COVID-19

Containing COVID-19 outside the isolation ward: the impact of an infection control bundle on environmental contamination and transmission in a cohorted general ward

Asymptomatic COVID-19 Patients Can Contaminate Their Surroundings: an Environment Sampling Study. mSphere 2020

Acknowledgments. We thank the DSO environmental detection team and clinical diagnostics team for BSL3 sample processing and analysis. We thank the logistics and repository team for transport of biohazard material, inventory, and safekeeping of received items. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. Conflicts of interest. All authors report no conflicts of interest relevant to this article.Supplementary material. To view supplementary material for this article, please visit https://doi.org/10.1017/ice.2020.1278

Total number of samples for both air and surface samples; exact number of surface samples not specified. c One sample, the inside of a closed suctioning tube, was excluded as we did not consider this an environmental sample. d Not stated in paper whether ICU samples were divided into rooms are common areas. Percentage reported is percentage positivity of all ICU samples. e Only samples taken before environmental decontamination were included.